In this Quick Take volume, Dr. James Phelps discusses research studies on the use of brexpiprazole for the treatment of borderline personality disorder as well as the use of psychotropic medications that act as functional inhibitors of acid sphingomyelinase (FIASMAs) for the prevention of serious medical outcomes among patients with COVID-19. He also examines systematic reviews on biomarkers of neuroprogression in bipolar disorder and the risks and benefits associated with the use of tranylcypromine in combination treatment. Finally, he presents recent guidelines on the management of psychosis in the context of mood disorders.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/quick-take-vol-40-2658?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-07-01 05:00:00
- End Date: 2022-07-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest